Serveur d'exploration sur la musique en Sarre

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function

Identifieur interne : 000E22 ( Istex/Corpus ); précédent : 000E21; suivant : 000E23

FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function

Auteurs : Kim Steen Jensen ; Tina Binderup ; Klaus Thorleif Jensen ; Ib Therkelsen ; Rehannah Borup ; Elise Nilsson ; Hinke Multhaupt ; Caroline Bouchard ; Bj Rn Quistorff ; Andreas Kj R ; Göran Landberg ; Peter Staller

Source :

RBID : ISTEX:8914E35786B08AB7269327A98613F0D81C65DF9D

English descriptors

Abstract

Exposure of metazoan organisms to hypoxia engages a metabolic switch orchestrated by the hypoxia‐inducible factor 1 (HIF‐1). HIF‐1 mediates induction of glycolysis and active repression of mitochondrial respiration that reduces oxygen consumption and inhibits the production of potentially harmful reactive oxygen species (ROS). Here, we show that FoxO3A is activated in hypoxia downstream of HIF‐1 and mediates the hypoxic repression of a set of nuclear‐encoded mitochondrial genes. FoxO3A is required for hypoxic suppression of mitochondrial mass, oxygen consumption, and ROS production and promotes cell survival in hypoxia. FoxO3A is recruited to the promoters of nuclear‐encoded mitochondrial genes where it directly antagonizes c‐Myc function via a mechanism that does not require binding to the consensus FoxO recognition element. Furthermore, we show that FoxO3A is activated in human hypoxic tumour tissue in vivo and that FoxO3A short‐hairpin RNA (shRNA)‐expressing xenograft tumours are decreased in size and metabolically changed. Our findings define a novel mechanism by which FoxO3A promotes metabolic adaptation and stress resistance in hypoxia.
This paper characterizes FoxO3A as required for hypoxic suppression of mitochondrial mass, oxygen consumption, and ROS production. Mechanistically, FoxO3A is shown to promote hypoxic cell survival by directly antagonizing c‐Myc at nuclear encoded mitochondrial genes.

Url:
DOI: 10.1038/emboj.2011.323

Links to Exploration step

ISTEX:8914E35786B08AB7269327A98613F0D81C65DF9D

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function</title>
<author>
<name sortKey="Jensen, Kim Steen" sort="Jensen, Kim Steen" uniqKey="Jensen K" first="Kim Steen" last="Jensen">Kim Steen Jensen</name>
<affiliation>
<mods:affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Binderup, Tina" sort="Binderup, Tina" uniqKey="Binderup T" first="Tina" last="Binderup">Tina Binderup</name>
<affiliation>
<mods:affiliation>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jensen, Klaus Thorleif" sort="Jensen, Klaus Thorleif" uniqKey="Jensen K" first="Klaus Thorleif" last="Jensen">Klaus Thorleif Jensen</name>
<affiliation>
<mods:affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Therkelsen, Ib" sort="Therkelsen, Ib" uniqKey="Therkelsen I" first="Ib" last="Therkelsen">Ib Therkelsen</name>
<affiliation>
<mods:affiliation>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Borup, Rehannah" sort="Borup, Rehannah" uniqKey="Borup R" first="Rehannah" last="Borup">Rehannah Borup</name>
<affiliation>
<mods:affiliation>Department of Clinical Biochemistry, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nilsson, Elise" sort="Nilsson, Elise" uniqKey="Nilsson E" first="Elise" last="Nilsson">Elise Nilsson</name>
<affiliation>
<mods:affiliation>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Multhaupt, Hinke" sort="Multhaupt, Hinke" uniqKey="Multhaupt H" first="Hinke" last="Multhaupt">Hinke Multhaupt</name>
<affiliation>
<mods:affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bouchard, Caroline" sort="Bouchard, Caroline" uniqKey="Bouchard C" first="Caroline" last="Bouchard">Caroline Bouchard</name>
<affiliation>
<mods:affiliation>Institute of Molecular Biology and Tumour Research, Philipps‐University of Marburg, Marburg, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Quistorff, Bj Rn" sort="Quistorff, Bj Rn" uniqKey="Quistorff B" first="Bj Rn" last="Quistorff">Bj Rn Quistorff</name>
<affiliation>
<mods:affiliation>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kj R, Andreas" sort="Kj R, Andreas" uniqKey="Kj R A" first="Andreas" last="Kj R">Andreas Kj R</name>
<affiliation>
<mods:affiliation>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Landberg, Goran" sort="Landberg, Goran" uniqKey="Landberg G" first="Göran" last="Landberg">Göran Landberg</name>
<affiliation>
<mods:affiliation>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Breakthrough Breast Cancer Research Unit, School of Cancer and Enabling Sciences, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Staller, Peter" sort="Staller, Peter" uniqKey="Staller P" first="Peter" last="Staller">Peter Staller</name>
<affiliation>
<mods:affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: peter.staller@bric.ku.dk</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:8914E35786B08AB7269327A98613F0D81C65DF9D</idno>
<date when="2011" year="2011">2011</date>
<idno type="doi">10.1038/emboj.2011.323</idno>
<idno type="url">https://api.istex.fr/document/8914E35786B08AB7269327A98613F0D81C65DF9D/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000E22</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000E22</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function</title>
<author>
<name sortKey="Jensen, Kim Steen" sort="Jensen, Kim Steen" uniqKey="Jensen K" first="Kim Steen" last="Jensen">Kim Steen Jensen</name>
<affiliation>
<mods:affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Binderup, Tina" sort="Binderup, Tina" uniqKey="Binderup T" first="Tina" last="Binderup">Tina Binderup</name>
<affiliation>
<mods:affiliation>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Jensen, Klaus Thorleif" sort="Jensen, Klaus Thorleif" uniqKey="Jensen K" first="Klaus Thorleif" last="Jensen">Klaus Thorleif Jensen</name>
<affiliation>
<mods:affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Therkelsen, Ib" sort="Therkelsen, Ib" uniqKey="Therkelsen I" first="Ib" last="Therkelsen">Ib Therkelsen</name>
<affiliation>
<mods:affiliation>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Borup, Rehannah" sort="Borup, Rehannah" uniqKey="Borup R" first="Rehannah" last="Borup">Rehannah Borup</name>
<affiliation>
<mods:affiliation>Department of Clinical Biochemistry, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Nilsson, Elise" sort="Nilsson, Elise" uniqKey="Nilsson E" first="Elise" last="Nilsson">Elise Nilsson</name>
<affiliation>
<mods:affiliation>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Multhaupt, Hinke" sort="Multhaupt, Hinke" uniqKey="Multhaupt H" first="Hinke" last="Multhaupt">Hinke Multhaupt</name>
<affiliation>
<mods:affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bouchard, Caroline" sort="Bouchard, Caroline" uniqKey="Bouchard C" first="Caroline" last="Bouchard">Caroline Bouchard</name>
<affiliation>
<mods:affiliation>Institute of Molecular Biology and Tumour Research, Philipps‐University of Marburg, Marburg, Germany</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Quistorff, Bj Rn" sort="Quistorff, Bj Rn" uniqKey="Quistorff B" first="Bj Rn" last="Quistorff">Bj Rn Quistorff</name>
<affiliation>
<mods:affiliation>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Kj R, Andreas" sort="Kj R, Andreas" uniqKey="Kj R A" first="Andreas" last="Kj R">Andreas Kj R</name>
<affiliation>
<mods:affiliation>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Landberg, Goran" sort="Landberg, Goran" uniqKey="Landberg G" first="Göran" last="Landberg">Göran Landberg</name>
<affiliation>
<mods:affiliation>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>Breakthrough Breast Cancer Research Unit, School of Cancer and Enabling Sciences, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Staller, Peter" sort="Staller, Peter" uniqKey="Staller P" first="Peter" last="Staller">Peter Staller</name>
<affiliation>
<mods:affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</mods:affiliation>
</affiliation>
<affiliation>
<mods:affiliation>E-mail: peter.staller@bric.ku.dk</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">The EMBO Journal</title>
<idno type="ISSN">0261-4189</idno>
<idno type="eISSN">1460-2075</idno>
<imprint>
<publisher>John Wiley & Sons, Ltd</publisher>
<pubPlace>Chichester, UK</pubPlace>
<date type="published" when="2011-11-16">2011-11-16</date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">22</biblScope>
<biblScope unit="page" from="4554">4554</biblScope>
<biblScope unit="page" to="4570">4570</biblScope>
</imprint>
<idno type="ISSN">0261-4189</idno>
</series>
<idno type="istex">8914E35786B08AB7269327A98613F0D81C65DF9D</idno>
<idno type="DOI">10.1038/emboj.2011.323</idno>
<idno type="ArticleID">EMBJ2011323</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0261-4189</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="Teeft" xml:lang="en">
<term>Aco2</term>
<term>Actin</term>
<term>Apoptosis</term>
<term>Biol</term>
<term>Biol chem</term>
<term>Biology organization</term>
<term>Biology organization foxo3a</term>
<term>Caspase</term>
<term>Cell biol</term>
<term>Cell clones</term>
<term>Cell death</term>
<term>Cell survival</term>
<term>Clone</term>
<term>Control hypoxic metabolism</term>
<term>Ctrl</term>
<term>Downregulate</term>
<term>Embo</term>
<term>Embo journal</term>
<term>Error bars</term>
<term>Fhre</term>
<term>Foxo</term>
<term>Foxo factors</term>
<term>Foxo3a</term>
<term>Foxo3a knockdown cell clones</term>
<term>Foxo3a knockdown cells</term>
<term>Gene</term>
<term>Glucose</term>
<term>Glucose uptake</term>
<term>Glycolytic</term>
<term>Hela</term>
<term>Hela cells</term>
<term>Hela ctrl</term>
<term>Hypoxia</term>
<term>Hypoxic</term>
<term>Hypoxic repression</term>
<term>Immunoblotting</term>
<term>Independent experiments</term>
<term>Knockdown</term>
<term>Lars2</term>
<term>Lower panel</term>
<term>Metabolic adaptation</term>
<term>Metabolism</term>
<term>Mitochondrial</term>
<term>Mitochondrial biogenesis</term>
<term>Mitochondrial genes</term>
<term>Mitochondrial mass</term>
<term>Mrna</term>
<term>Mrna levels</term>
<term>Normoxia</term>
<term>Oxnad1</term>
<term>Oxygen consumption</term>
<term>Probe sets</term>
<term>Promoter</term>
<term>Protein levels</term>
<term>Qpcr</term>
<term>Sirna</term>
<term>Subunit</term>
<term>Supplementary figure</term>
<term>Supplementary table</term>
<term>Target genes</term>
<term>Transcription</term>
<term>Transcriptional</term>
<term>Transfected</term>
<term>Tumour</term>
<term>U2os</term>
<term>U2os cell clones</term>
<term>Xenograft</term>
<term>Xenograft tumours</term>
<term>Zhang</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Exposure of metazoan organisms to hypoxia engages a metabolic switch orchestrated by the hypoxia‐inducible factor 1 (HIF‐1). HIF‐1 mediates induction of glycolysis and active repression of mitochondrial respiration that reduces oxygen consumption and inhibits the production of potentially harmful reactive oxygen species (ROS). Here, we show that FoxO3A is activated in hypoxia downstream of HIF‐1 and mediates the hypoxic repression of a set of nuclear‐encoded mitochondrial genes. FoxO3A is required for hypoxic suppression of mitochondrial mass, oxygen consumption, and ROS production and promotes cell survival in hypoxia. FoxO3A is recruited to the promoters of nuclear‐encoded mitochondrial genes where it directly antagonizes c‐Myc function via a mechanism that does not require binding to the consensus FoxO recognition element. Furthermore, we show that FoxO3A is activated in human hypoxic tumour tissue in vivo and that FoxO3A short‐hairpin RNA (shRNA)‐expressing xenograft tumours are decreased in size and metabolically changed. Our findings define a novel mechanism by which FoxO3A promotes metabolic adaptation and stress resistance in hypoxia.</div>
<div type="abstract">This paper characterizes FoxO3A as required for hypoxic suppression of mitochondrial mass, oxygen consumption, and ROS production. Mechanistically, FoxO3A is shown to promote hypoxic cell survival by directly antagonizing c‐Myc at nuclear encoded mitochondrial genes.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<keywords>
<teeft>
<json:string>foxo3a</json:string>
<json:string>hypoxia</json:string>
<json:string>ctrl</json:string>
<json:string>mitochondrial</json:string>
<json:string>hypoxic</json:string>
<json:string>tumour</json:string>
<json:string>clone</json:string>
<json:string>normoxia</json:string>
<json:string>knockdown</json:string>
<json:string>sirna</json:string>
<json:string>hela</json:string>
<json:string>mitochondrial genes</json:string>
<json:string>embo</json:string>
<json:string>foxo</json:string>
<json:string>supplementary figure</json:string>
<json:string>foxo3a knockdown cell clones</json:string>
<json:string>embo journal</json:string>
<json:string>foxo3a knockdown cells</json:string>
<json:string>aco2</json:string>
<json:string>control hypoxic metabolism</json:string>
<json:string>transcriptional</json:string>
<json:string>oxygen consumption</json:string>
<json:string>glucose</json:string>
<json:string>xenograft</json:string>
<json:string>oxnad1</json:string>
<json:string>u2os</json:string>
<json:string>biol</json:string>
<json:string>lars2</json:string>
<json:string>error bars</json:string>
<json:string>hela ctrl</json:string>
<json:string>transfected</json:string>
<json:string>mrna</json:string>
<json:string>qpcr</json:string>
<json:string>metabolic adaptation</json:string>
<json:string>promoter</json:string>
<json:string>probe sets</json:string>
<json:string>caspase</json:string>
<json:string>fhre</json:string>
<json:string>zhang</json:string>
<json:string>mitochondrial mass</json:string>
<json:string>actin</json:string>
<json:string>biology organization foxo3a</json:string>
<json:string>immunoblotting</json:string>
<json:string>apoptosis</json:string>
<json:string>hypoxic repression</json:string>
<json:string>glycolytic</json:string>
<json:string>target genes</json:string>
<json:string>foxo factors</json:string>
<json:string>subunit</json:string>
<json:string>glucose uptake</json:string>
<json:string>downregulate</json:string>
<json:string>metabolism</json:string>
<json:string>hela cells</json:string>
<json:string>independent experiments</json:string>
<json:string>supplementary table</json:string>
<json:string>protein levels</json:string>
<json:string>biology organization</json:string>
<json:string>cell death</json:string>
<json:string>biol chem</json:string>
<json:string>gene</json:string>
<json:string>mrna levels</json:string>
<json:string>xenograft tumours</json:string>
<json:string>lower panel</json:string>
<json:string>cell clones</json:string>
<json:string>cell survival</json:string>
<json:string>mitochondrial biogenesis</json:string>
<json:string>cell biol</json:string>
<json:string>u2os cell clones</json:string>
<json:string>transcription</json:string>
<json:string>upper panel</json:string>
<json:string>endogenous foxo3a</json:string>
<json:string>control group</json:string>
<json:string>foxo transcription factors</json:string>
<json:string>control cells</json:string>
<json:string>mitochondrial function</json:string>
<json:string>cancer cell</json:string>
<json:string>metabolic</json:string>
<json:string>foxo3a protein</json:string>
<json:string>u2os cells transiently transfected</json:string>
<json:string>hypoxic stress</json:string>
<json:string>cell numbers</json:string>
<json:string>many genes</json:string>
<json:string>antioxidant trolox</json:string>
<json:string>present study</json:string>
<json:string>normoxic ctrl</json:string>
<json:string>tissue culture experiments</json:string>
<json:string>sirna oligos</json:string>
<json:string>hypoxic induction</json:string>
<json:string>mitochondrial autophagy</json:string>
<json:string>hypoxic response</json:string>
<json:string>peak binding</json:string>
<json:string>ctrl cells</json:string>
<json:string>mrna expression</json:string>
<json:string>oxidative stress</json:string>
<json:string>cell metab</json:string>
<json:string>transcriptional induction</json:string>
<json:string>foxo3a norm</json:string>
<json:string>negative control</json:string>
<json:string>percentage error bars</json:string>
<json:string>important role</json:string>
<json:string>immunohistochemical stainings</json:string>
<json:string>nude mice</json:string>
<json:string>foxo3a knockdown</json:string>
<json:string>foxo3a knockdown tumours</json:string>
<json:string>control tumours</json:string>
<json:string>hypoxic conditions</json:string>
<json:string>nonyl acridine</json:string>
<json:string>recent study</json:string>
<json:string>hypoxic treatment</json:string>
<json:string>santa cruz biotechnology</json:string>
<json:string>proc natl acad</json:string>
<json:string>metabolic switch</json:string>
<json:string>full media</json:string>
<json:string>control counterparts</json:string>
<json:string>microarray data</json:string>
<json:string>statistical analysis</json:string>
</teeft>
</keywords>
<author>
<json:item>
<name>Kim Steen Jensen</name>
<affiliations>
<json:string>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>Tina Binderup</name>
<affiliations>
<json:string>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark</json:string>
<json:string>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>Klaus Thorleif Jensen</name>
<affiliations>
<json:string>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>Ib Therkelsen</name>
<affiliations>
<json:string>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>Rehannah Borup</name>
<affiliations>
<json:string>Department of Clinical Biochemistry, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>Elise Nilsson</name>
<affiliations>
<json:string>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden</json:string>
</affiliations>
</json:item>
<json:item>
<name>Hinke Multhaupt</name>
<affiliations>
<json:string>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>Caroline Bouchard</name>
<affiliations>
<json:string>Institute of Molecular Biology and Tumour Research, Philipps‐University of Marburg, Marburg, Germany</json:string>
</affiliations>
</json:item>
<json:item>
<name>Bjørn Quistorff</name>
<affiliations>
<json:string>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>Andreas Kjær</name>
<affiliations>
<json:string>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark</json:string>
<json:string>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</json:string>
</affiliations>
</json:item>
<json:item>
<name>Göran Landberg</name>
<affiliations>
<json:string>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden</json:string>
<json:string>Breakthrough Breast Cancer Research Unit, School of Cancer and Enabling Sciences, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK</json:string>
</affiliations>
</json:item>
<json:item>
<name>Peter Staller</name>
<affiliations>
<json:string>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</json:string>
<json:string>E-mail: peter.staller@bric.ku.dk</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>FoxO3A</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>hypoxia</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>metabolism</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>mitochondrion</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Myc</value>
</json:item>
</subject>
<articleId>
<json:string>EMBJ2011323</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<originalGenre>
<json:string>article</json:string>
</originalGenre>
<qualityIndicators>
<score>8.456</score>
<pdfVersion>1.6</pdfVersion>
<pdfPageSize>595.276 x 793.701 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<abstractCharCount>1160</abstractCharCount>
<pdfWordCount>9894</pdfWordCount>
<pdfCharCount>65775</pdfCharCount>
<pdfPageCount>17</pdfPageCount>
<abstractWordCount>163</abstractWordCount>
</qualityIndicators>
<title>FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function</title>
<genre>
<json:string>article</json:string>
</genre>
<host>
<title>The EMBO Journal</title>
<language>
<json:string>unknown</json:string>
</language>
<doi>
<json:string>10.1002/(ISSN)1460-2075</json:string>
</doi>
<issn>
<json:string>0261-4189</json:string>
</issn>
<eissn>
<json:string>1460-2075</json:string>
</eissn>
<publisherId>
<json:string>EMBJ</json:string>
</publisherId>
<volume>30</volume>
<issue>22</issue>
<pages>
<first>4554</first>
<last>4570</last>
<total>17</total>
</pages>
<genre>
<json:string>journal</json:string>
</genre>
<subject>
<json:item>
<value>Signal Transduction</value>
</json:item>
<json:item>
<value>Molecular Biology of Disease</value>
</json:item>
<json:item>
<value>Article</value>
</json:item>
</subject>
</host>
<categories>
<wos>
<json:string>science</json:string>
<json:string>cell biology</json:string>
<json:string>biochemistry & molecular biology</json:string>
</wos>
<scienceMetrix>
<json:string>health sciences</json:string>
<json:string>biomedical research</json:string>
<json:string>developmental biology</json:string>
</scienceMetrix>
</categories>
<publicationDate>2011</publicationDate>
<copyrightDate>2011</copyrightDate>
<doi>
<json:string>10.1038/emboj.2011.323</json:string>
</doi>
<id>8914E35786B08AB7269327A98613F0D81C65DF9D</id>
<score>1</score>
<fulltext>
<json:item>
<extension>pdf</extension>
<original>true</original>
<mimetype>application/pdf</mimetype>
<uri>https://api.istex.fr/document/8914E35786B08AB7269327A98613F0D81C65DF9D/fulltext/pdf</uri>
</json:item>
<json:item>
<extension>zip</extension>
<original>false</original>
<mimetype>application/zip</mimetype>
<uri>https://api.istex.fr/document/8914E35786B08AB7269327A98613F0D81C65DF9D/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/8914E35786B08AB7269327A98613F0D81C65DF9D/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>John Wiley & Sons, Ltd</publisher>
<pubPlace>Chichester, UK</pubPlace>
<availability>
<p>Copyright © 2013 Wiley Periodicals, IncCopyright © 2011 European Molecular Biology Organization</p>
</availability>
<date>2011</date>
</publicationStmt>
<notesStmt>
<note>Supplementary InformationSupplementary Table S1Supplementary Table S2Supplementary Table S3Supplementary Table S4Supplementary Table S5Supplementary Table S6Supplementary Table S7Supplementary Table S8Review Process File</note>
</notesStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function</title>
<author xml:id="author-1">
<persName>
<forename type="first">Kim Steen</forename>
<surname>Jensen</surname>
</persName>
<affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</affiliation>
</author>
<author xml:id="author-2">
<persName>
<forename type="first">Tina</forename>
<surname>Binderup</surname>
</persName>
<affiliation>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark</affiliation>
<affiliation>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</affiliation>
</author>
<author xml:id="author-3">
<persName>
<forename type="first">Klaus Thorleif</forename>
<surname>Jensen</surname>
</persName>
<affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</affiliation>
</author>
<author xml:id="author-4">
<persName>
<forename type="first">Ib</forename>
<surname>Therkelsen</surname>
</persName>
<affiliation>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</affiliation>
</author>
<author xml:id="author-5">
<persName>
<forename type="first">Rehannah</forename>
<surname>Borup</surname>
</persName>
<affiliation>Department of Clinical Biochemistry, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark</affiliation>
</author>
<author xml:id="author-6">
<persName>
<forename type="first">Elise</forename>
<surname>Nilsson</surname>
</persName>
<affiliation>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden</affiliation>
</author>
<author xml:id="author-7">
<persName>
<forename type="first">Hinke</forename>
<surname>Multhaupt</surname>
</persName>
<affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</affiliation>
</author>
<author xml:id="author-8">
<persName>
<forename type="first">Caroline</forename>
<surname>Bouchard</surname>
</persName>
<affiliation>Institute of Molecular Biology and Tumour Research, Philipps‐University of Marburg, Marburg, Germany</affiliation>
</author>
<author xml:id="author-9">
<persName>
<forename type="first">Bjørn</forename>
<surname>Quistorff</surname>
</persName>
<affiliation>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</affiliation>
</author>
<author xml:id="author-10">
<persName>
<forename type="first">Andreas</forename>
<surname>Kjær</surname>
</persName>
<affiliation>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark</affiliation>
<affiliation>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</affiliation>
</author>
<author xml:id="author-11">
<persName>
<forename type="first">Göran</forename>
<surname>Landberg</surname>
</persName>
<affiliation>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden</affiliation>
<affiliation>Breakthrough Breast Cancer Research Unit, School of Cancer and Enabling Sciences, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK</affiliation>
</author>
<author xml:id="author-12">
<persName>
<forename type="first">Peter</forename>
<surname>Staller</surname>
</persName>
<email>peter.staller@bric.ku.dk</email>
<note type="biography">Present address: EpiTherapeutics, Copenhagen, Denmark. E‐mail: ps@epitherapeutics.dk</note>
<affiliation>Present address: EpiTherapeutics, Copenhagen, Denmark. E‐mail: ps@epitherapeutics.dk</affiliation>
<affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</affiliation>
</author>
</analytic>
<monogr>
<title level="j">The EMBO Journal</title>
<idno type="pISSN">0261-4189</idno>
<idno type="eISSN">1460-2075</idno>
<idno type="DOI">10.1002/(ISSN)1460-2075</idno>
<imprint>
<publisher>John Wiley & Sons, Ltd</publisher>
<pubPlace>Chichester, UK</pubPlace>
<date type="published" when="2011-11-16"></date>
<biblScope unit="volume">30</biblScope>
<biblScope unit="issue">22</biblScope>
<biblScope unit="page" from="4554">4554</biblScope>
<biblScope unit="page" to="4570">4570</biblScope>
</imprint>
</monogr>
<idno type="istex">8914E35786B08AB7269327A98613F0D81C65DF9D</idno>
<idno type="DOI">10.1038/emboj.2011.323</idno>
<idno type="ArticleID">EMBJ2011323</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2011</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract>
<p>Exposure of metazoan organisms to hypoxia engages a metabolic switch orchestrated by the hypoxia‐inducible factor 1 (HIF‐1). HIF‐1 mediates induction of glycolysis and active repression of mitochondrial respiration that reduces oxygen consumption and inhibits the production of potentially harmful reactive oxygen species (ROS). Here, we show that FoxO3A is activated in hypoxia downstream of HIF‐1 and mediates the hypoxic repression of a set of nuclear‐encoded mitochondrial genes. FoxO3A is required for hypoxic suppression of mitochondrial mass, oxygen consumption, and ROS production and promotes cell survival in hypoxia. FoxO3A is recruited to the promoters of nuclear‐encoded mitochondrial genes where it directly antagonizes c‐Myc function via a mechanism that does not require binding to the consensus FoxO recognition element. Furthermore, we show that FoxO3A is activated in human hypoxic tumour tissue in vivo and that FoxO3A short‐hairpin RNA (shRNA)‐expressing xenograft tumours are decreased in size and metabolically changed. Our findings define a novel mechanism by which FoxO3A promotes metabolic adaptation and stress resistance in hypoxia.</p>
</abstract>
<abstract style="short">
<p>This paper characterizes FoxO3A as required for hypoxic suppression of mitochondrial mass, oxygen consumption, and ROS production. Mechanistically, FoxO3A is shown to promote hypoxic cell survival by directly antagonizing c‐Myc at nuclear encoded mitochondrial genes.</p>
</abstract>
<textClass>
<keywords scheme="keyword">
<list>
<head>keywords</head>
<item>
<term>FoxO3A</term>
</item>
<item>
<term>hypoxia</term>
</item>
<item>
<term>metabolism</term>
</item>
<item>
<term>mitochondrion</term>
</item>
<item>
<term>Myc</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>index-terms</head>
<item>
<term>Signal Transduction</term>
</item>
<item>
<term>Molecular Biology of Disease</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>article-category</head>
<item>
<term>Article</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2011-03-27">Received</change>
<change when="2011-08-15">Registration</change>
<change when="2011-11-16">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<extension>txt</extension>
<original>false</original>
<mimetype>text/plain</mimetype>
<uri>https://api.istex.fr/document/8914E35786B08AB7269327A98613F0D81C65DF9D/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component type="serialArticle" version="2.0" xml:lang="en" xml:id="embj2011323">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>John Wiley & Sons, Ltd</publisherName>
<publisherLoc>Chichester, UK</publisherLoc>
</publisherInfo>
<doi>10.1002/(ISSN)1460-2075</doi>
<issn type="print">0261-4189</issn>
<issn type="electronic">1460-2075</issn>
<idGroup>
<id type="product" value="EMBJ"></id>
</idGroup>
<titleGroup>
<title type="main" sort="THE EMBO JOURNAL">The EMBO Journal</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="220">
<doi>10.1002/emboj.v30.22</doi>
<copyright ownership="publisher">Copyright © 2013 Wiley Periodicals, Inc</copyright>
<numberingGroup>
<numbering type="journalVolume" number="30">30</numbering>
<numbering type="journalIssue">22</numbering>
</numberingGroup>
<coverDate startDate="2011-11-16">November 16, 2011</coverDate>
</publicationMeta>
<publicationMeta level="unit" position="50" type="article" status="forIssue">
<doi>10.1038/emboj.2011.323</doi>
<idGroup>
<id type="unit" value="EMBJ2011323"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="17"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Article</title>
<title type="tocHeading1">Article</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2011 European Molecular Biology Organization</copyright>
<eventGroup>
<event type="manuscriptReceived" date="2011-03-27"></event>
<event type="manuscriptAccepted" date="2011-08-15"></event>
<event type="publishedOnlineEarlyUnpaginated" date="2011-09-13"></event>
<event type="publishedOnlineFinalForm" date="2011-11-16"></event>
<event type="xmlConverted" agent="SPi Global Converter_TO_WileyML3Gv2.0 version:1.0; WileyML 3G Packaging Tool v1.0" date="2013-10-22"></event>
<event type="firstOnline" date="2011-09-13"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-11-04"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">4554</numbering>
<numbering type="pageLast">4570</numbering>
</numberingGroup>
<correspondenceTo>Corresponding author. Biotech Research and Innovation Centre, University of Copenhagen, Ole Maaløes Vej 5, Copenhagen DK‐2200, Denmark. Tel.: +45 3532 5682; Fax: +45 3532 5669; E‐mail:
<email>peter.staller@bric.ku.dk</email>
</correspondenceTo>
<subjectInfo>
<subject href="http://psi.embo.org/14602075/EMBO37">Signal Transduction</subject>
<subject href="http://psi.embo.org/14602075/EMBO24">Molecular Biology of Disease</subject>
</subjectInfo>
<attributeValueGroup>
<attributeValue element="note" attribute="type" value="present-address"></attributeValue>
</attributeValueGroup>
<linkGroup>
<link type="toTypesetVersion" href="file:EMBJ.EMBJ2011323.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<titleGroup>
<title type="main">FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function</title>
<title type="short">FoxO3A inhibits Myc to control hypoxic metabolism</title>
</titleGroup>
<creators>
<creator creatorRole="author" xml:id="embj2011323-cr-0001" affiliationRef="#embj2011323-aff-0001">
<personName>
<givenNames>Kim Steen</givenNames>
<familyName>Jensen</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0002" affiliationRef="#embj2011323-aff-0002 #embj2011323-aff-0003">
<personName>
<givenNames>Tina</givenNames>
<familyName>Binderup</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0003" affiliationRef="#embj2011323-aff-0001">
<personName>
<givenNames>Klaus Thorleif</givenNames>
<familyName>Jensen</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0004" affiliationRef="#embj2011323-aff-0004">
<personName>
<givenNames>Ib</givenNames>
<familyName>Therkelsen</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0005" affiliationRef="#embj2011323-aff-0005">
<personName>
<givenNames>Rehannah</givenNames>
<familyName>Borup</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0006" affiliationRef="#embj2011323-aff-0006">
<personName>
<givenNames>Elise</givenNames>
<familyName>Nilsson</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0007" affiliationRef="#embj2011323-aff-0001">
<personName>
<givenNames>Hinke</givenNames>
<familyName>Multhaupt</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0008" affiliationRef="#embj2011323-aff-0007">
<personName>
<givenNames>Caroline</givenNames>
<familyName>Bouchard</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0009" affiliationRef="#embj2011323-aff-0004">
<personName>
<givenNames>Bjørn</givenNames>
<familyName>Quistorff</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0010" affiliationRef="#embj2011323-aff-0002 #embj2011323-aff-0003">
<personName>
<givenNames>Andreas</givenNames>
<familyName>Kjær</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0011" affiliationRef="#embj2011323-aff-0006 #embj2011323-aff-0008">
<personName>
<givenNames>Göran</givenNames>
<familyName>Landberg</familyName>
</personName>
</creator>
<creator creatorRole="author" xml:id="embj2011323-cr-0012" affiliationRef="#embj2011323-aff-0001" noteRef="#embj2011323-note-0001" corresponding="yes">
<personName>
<givenNames>Peter</givenNames>
<familyName>Staller</familyName>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation countryCode="DK" type="organization" xml:id="embj2011323-aff-0001">
<orgName>Biotech Research and Innovation Centre (BRIC), University of Copenhagen</orgName>
<address>
<city>Copenhagen</city>
<country>Denmark</country>
</address>
</affiliation>
<affiliation countryCode="DK" type="organization" xml:id="embj2011323-aff-0002">
<orgName>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet</orgName>
<address>
<city>Copenhagen</city>
<country>Denmark</country>
</address>
</affiliation>
<affiliation countryCode="DK" type="organization" xml:id="embj2011323-aff-0003">
<orgName>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen</orgName>
<address>
<city>Copenhagen</city>
<country>Denmark</country>
</address>
</affiliation>
<affiliation countryCode="DK" type="organization" xml:id="embj2011323-aff-0004">
<orgName>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen</orgName>
<address>
<city>Copenhagen</city>
<country>Denmark</country>
</address>
</affiliation>
<affiliation countryCode="DK" type="organization" xml:id="embj2011323-aff-0005">
<orgName>Department of Clinical Biochemistry, University of Copenhagen, Rigshospitalet</orgName>
<address>
<city>Copenhagen</city>
<country>Denmark</country>
</address>
</affiliation>
<affiliation countryCode="SE" type="organization" xml:id="embj2011323-aff-0006">
<orgName>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital</orgName>
<address>
<city>Malmö</city>
<country>Sweden</country>
</address>
</affiliation>
<affiliation countryCode="DE" type="organization" xml:id="embj2011323-aff-0007">
<orgName>Institute of Molecular Biology and Tumour Research, Philipps‐University of Marburg</orgName>
<address>
<city>Marburg</city>
<country>Germany</country>
</address>
</affiliation>
<affiliation countryCode="" type="organization" xml:id="embj2011323-aff-0008">
<orgName>Breakthrough Breast Cancer Research Unit, School of Cancer and Enabling Sciences, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, University of Manchester</orgName>
<address>
<city>Manchester</city>
<country>UK</country>
</address>
</affiliation>
</affiliationGroup>
<keywordGroup type="author">
<keyword xml:id="embj2011323-kwd-0001">FoxO3A</keyword>
<keyword xml:id="embj2011323-kwd-0002">hypoxia</keyword>
<keyword xml:id="embj2011323-kwd-0003">metabolism</keyword>
<keyword xml:id="embj2011323-kwd-0004">mitochondrion</keyword>
<keyword xml:id="embj2011323-kwd-0005">Myc</keyword>
</keywordGroup>
<supportingInformation>
<supportingInfoItem xml:id="embj2011323-sup-0001">
<mediaResource alt="supplementary data" mimeType="application/pdf" href="urn-x:wiley:02614189:media:embj2011323:embj2011323-sup-0001"></mediaResource>
<caption>Supplementary Information</caption>
</supportingInfoItem>
<supportingInfoItem xml:id="embj2011323-sup-0002">
<mediaResource alt="supplementary data" mimeType="application/xls" href="urn-x:wiley:02614189:media:embj2011323:embj2011323-sup-0002"></mediaResource>
<caption>Supplementary Table S1</caption>
</supportingInfoItem>
<supportingInfoItem xml:id="embj2011323-sup-0003">
<mediaResource alt="supplementary data" mimeType="application/xls" href="urn-x:wiley:02614189:media:embj2011323:embj2011323-sup-0003"></mediaResource>
<caption>Supplementary Table S2</caption>
</supportingInfoItem>
<supportingInfoItem xml:id="embj2011323-sup-0004">
<mediaResource alt="supplementary data" mimeType="application/xls" href="urn-x:wiley:02614189:media:embj2011323:embj2011323-sup-0004"></mediaResource>
<caption>Supplementary Table S3</caption>
</supportingInfoItem>
<supportingInfoItem xml:id="embj2011323-sup-0005">
<mediaResource alt="supplementary data" mimeType="application/xls" href="urn-x:wiley:02614189:media:embj2011323:embj2011323-sup-0005"></mediaResource>
<caption>Supplementary Table S4</caption>
</supportingInfoItem>
<supportingInfoItem xml:id="embj2011323-sup-0006">
<mediaResource alt="supplementary data" mimeType="application/doc" href="urn-x:wiley:02614189:media:embj2011323:embj2011323-sup-0006"></mediaResource>
<caption>Supplementary Table S5</caption>
</supportingInfoItem>
<supportingInfoItem xml:id="embj2011323-sup-0007">
<mediaResource alt="supplementary data" mimeType="application/doc" href="urn-x:wiley:02614189:media:embj2011323:embj2011323-sup-0007"></mediaResource>
<caption>Supplementary Table S6</caption>
</supportingInfoItem>
<supportingInfoItem xml:id="embj2011323-sup-0008">
<mediaResource alt="supplementary data" mimeType="application/doc" href="urn-x:wiley:02614189:media:embj2011323:embj2011323-sup-0008"></mediaResource>
<caption>Supplementary Table S7</caption>
</supportingInfoItem>
<supportingInfoItem xml:id="embj2011323-sup-0009">
<mediaResource alt="supplementary data" mimeType="application/doc" href="urn-x:wiley:02614189:media:embj2011323:embj2011323-sup-0009"></mediaResource>
<caption>Supplementary Table S8</caption>
</supportingInfoItem>
<supportingInfoItem xml:id="embj2011323-sup-0010">
<mediaResource alt="supplementary data" mimeType="application/pdf" href="urn-x:wiley:02614189:media:embj2011323:embj2011323"></mediaResource>
<caption>Review Process File</caption>
</supportingInfoItem>
</supportingInformation>
<abstractGroup>
<abstract type="main">
<p>Exposure of metazoan organisms to hypoxia engages a metabolic switch orchestrated by the hypoxia‐inducible factor 1 (HIF‐1). HIF‐1 mediates induction of glycolysis and active repression of mitochondrial respiration that reduces oxygen consumption and inhibits the production of potentially harmful reactive oxygen species (ROS). Here, we show that FoxO3A is activated in hypoxia downstream of HIF‐1 and mediates the hypoxic repression of a set of nuclear‐encoded mitochondrial genes. FoxO3A is required for hypoxic suppression of mitochondrial mass, oxygen consumption, and ROS production and promotes cell survival in hypoxia. FoxO3A is recruited to the promoters of nuclear‐encoded mitochondrial genes where it directly antagonizes c‐Myc function via a mechanism that does not require binding to the consensus FoxO recognition element. Furthermore, we show that FoxO3A is activated in human hypoxic tumour tissue
<i>in vivo</i>
and that FoxO3A short‐hairpin RNA (shRNA)‐expressing xenograft tumours are decreased in size and metabolically changed. Our findings define a novel mechanism by which FoxO3A promotes metabolic adaptation and stress resistance in hypoxia.</p>
</abstract>
<abstract type="short">
<p>This paper characterizes FoxO3A as required for hypoxic suppression of mitochondrial mass, oxygen consumption, and ROS production. Mechanistically, FoxO3A is shown to promote hypoxic cell survival by directly antagonizing c‐Myc at nuclear encoded mitochondrial genes.</p>
</abstract>
</abstractGroup>
</contentMeta>
<noteGroup>
<note xml:id="embj2011323-note-0001" type="present-address">Present address: EpiTherapeutics, Copenhagen, Denmark. E‐mail:
<email>ps@epitherapeutics.dk</email>
</note>
</noteGroup>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>FoxO3A inhibits Myc to control hypoxic metabolism</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function</title>
</titleInfo>
<name type="personal">
<namePart type="given">Kim Steen</namePart>
<namePart type="family">Jensen</namePart>
<affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Tina</namePart>
<namePart type="family">Binderup</namePart>
<affiliation>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark</affiliation>
<affiliation>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Klaus Thorleif</namePart>
<namePart type="family">Jensen</namePart>
<affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Ib</namePart>
<namePart type="family">Therkelsen</namePart>
<affiliation>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Rehannah</namePart>
<namePart type="family">Borup</namePart>
<affiliation>Department of Clinical Biochemistry, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Elise</namePart>
<namePart type="family">Nilsson</namePart>
<affiliation>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Hinke</namePart>
<namePart type="family">Multhaupt</namePart>
<affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Caroline</namePart>
<namePart type="family">Bouchard</namePart>
<affiliation>Institute of Molecular Biology and Tumour Research, Philipps‐University of Marburg, Marburg, Germany</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Bjørn</namePart>
<namePart type="family">Quistorff</namePart>
<affiliation>Department of Biomedical Sciences, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Andreas</namePart>
<namePart type="family">Kjær</namePart>
<affiliation>Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen, Denmark</affiliation>
<affiliation>Cluster for Molecular Imaging, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Göran</namePart>
<namePart type="family">Landberg</namePart>
<affiliation>Department of Laboratory Medicine, Center for Molecular Pathology, Lund University, Malmö University Hospital, Malmö, Sweden</affiliation>
<affiliation>Breakthrough Breast Cancer Research Unit, School of Cancer and Enabling Sciences, Manchester Academic Health Science Centre, Paterson Institute for Cancer Research, University of Manchester, Manchester, UK</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Peter</namePart>
<namePart type="family">Staller</namePart>
<affiliation>Biotech Research and Innovation Centre (BRIC), University of Copenhagen, Copenhagen, Denmark</affiliation>
<description>Present address: EpiTherapeutics, Copenhagen, Denmark. E‐mail: ps@epitherapeutics.dk</description>
<affiliation>E-mail: peter.staller@bric.ku.dk</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo>
<publisher>John Wiley & Sons, Ltd</publisher>
<place>
<placeTerm type="text">Chichester, UK</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2011-11-16</dateIssued>
<dateCaptured encoding="w3cdtf">2011-03-27</dateCaptured>
<dateValid encoding="w3cdtf">2011-08-15</dateValid>
<copyrightDate encoding="w3cdtf">2011</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
</physicalDescription>
<abstract>Exposure of metazoan organisms to hypoxia engages a metabolic switch orchestrated by the hypoxia‐inducible factor 1 (HIF‐1). HIF‐1 mediates induction of glycolysis and active repression of mitochondrial respiration that reduces oxygen consumption and inhibits the production of potentially harmful reactive oxygen species (ROS). Here, we show that FoxO3A is activated in hypoxia downstream of HIF‐1 and mediates the hypoxic repression of a set of nuclear‐encoded mitochondrial genes. FoxO3A is required for hypoxic suppression of mitochondrial mass, oxygen consumption, and ROS production and promotes cell survival in hypoxia. FoxO3A is recruited to the promoters of nuclear‐encoded mitochondrial genes where it directly antagonizes c‐Myc function via a mechanism that does not require binding to the consensus FoxO recognition element. Furthermore, we show that FoxO3A is activated in human hypoxic tumour tissue in vivo and that FoxO3A short‐hairpin RNA (shRNA)‐expressing xenograft tumours are decreased in size and metabolically changed. Our findings define a novel mechanism by which FoxO3A promotes metabolic adaptation and stress resistance in hypoxia.</abstract>
<abstract type="short">This paper characterizes FoxO3A as required for hypoxic suppression of mitochondrial mass, oxygen consumption, and ROS production. Mechanistically, FoxO3A is shown to promote hypoxic cell survival by directly antagonizing c‐Myc at nuclear encoded mitochondrial genes.</abstract>
<note type="additional physical form">Supplementary InformationSupplementary Table S1Supplementary Table S2Supplementary Table S3Supplementary Table S4Supplementary Table S5Supplementary Table S6Supplementary Table S7Supplementary Table S8Review Process File</note>
<subject>
<genre>keywords</genre>
<topic>FoxO3A</topic>
<topic>hypoxia</topic>
<topic>metabolism</topic>
<topic>mitochondrion</topic>
<topic>Myc</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>The EMBO Journal</title>
</titleInfo>
<genre type="journal">journal</genre>
<subject>
<genre>index-terms</genre>
<topic authorityURI="http://psi.embo.org/14602075/EMBO37">Signal Transduction</topic>
<topic authorityURI="http://psi.embo.org/14602075/EMBO24">Molecular Biology of Disease</topic>
</subject>
<subject>
<genre>article-category</genre>
<topic>Article</topic>
</subject>
<identifier type="ISSN">0261-4189</identifier>
<identifier type="eISSN">1460-2075</identifier>
<identifier type="DOI">10.1002/(ISSN)1460-2075</identifier>
<identifier type="PublisherID">EMBJ</identifier>
<part>
<date>2011</date>
<detail type="volume">
<caption>vol.</caption>
<number>30</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>22</number>
</detail>
<extent unit="pages">
<start>4554</start>
<end>4570</end>
<total>17</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">8914E35786B08AB7269327A98613F0D81C65DF9D</identifier>
<identifier type="DOI">10.1038/emboj.2011.323</identifier>
<identifier type="ArticleID">EMBJ2011323</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2013 Wiley Periodicals, IncCopyright © 2011 European Molecular Biology Organization</accessCondition>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>John Wiley & Sons, Ltd</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sarre/explor/MusicSarreV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000E22 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000E22 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sarre
   |area=    MusicSarreV3
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:8914E35786B08AB7269327A98613F0D81C65DF9D
   |texte=   FoxO3A promotes metabolic adaptation to hypoxia by antagonizing Myc function
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sun Jul 15 18:16:09 2018. Site generation: Tue Mar 5 19:21:25 2024